Organoids are being explored as a potential new approach in pre-clinical research, possibly replacing traditional methods. This development may lead to changes in drug development, with some outlets suggesting that organoids could accelerate smarter drug decisions and redefine the field. The use of organoids in research appears to be gaining traction, with various studies and programs, including those focused on cancer and mitochondrial donation, underway to investigate their potential.